glp-1 drug manufacturers 2025’s Breakthrough Obesity Treatments: Top Companies & Innovations Insurance stopped covering your GLP-1?

Weight loss drugs targeting the hypothalamus often converge on the leptinmelanocortin pathway

Pharmacological guidance recommends discontinuing therapy after at least 5 half-lives to minimize fetal exposure

Use with caution to the elderly patient who is using diuretics

If you want to learn more about the Bariatric and Obesity Medicine services at Garnet Health, visit garnethealth.org/bariatricprogram or call (845) 333-2123.

Neurofibrillary tangles have been found in the amygdala, hippocampal structure, parahippocampal gyrus, and temporal cortex of patients with AD, whereas senile plaques have been shown to be distributed throughout the combined neocortex and striatum (41)

A phase 2 52-week study reports a mean weight loss of 17% and 20% in participants with and without T2D, respectively (71)